Durable Mechanical Circulatory Support versus Organ Transplantation: Past, Present, and Future

Figure 2

The hospitalization experience of the REMATCH trial—this figure illustrates the stark contrast in survival and hospital days between REMATCH trial patients who received optimal medical management versus LVAD therapy with a HeartMate XVE [16].